Your browser doesn't support javascript.
loading
Publicada a RDC Anvisa n. 395 que altera a Resolução de Diretoria Colegiada ­ RDC n° 352, de 20 de março de 2020, que dispõe sobre a autorização prévia para fins de exportação de matéria-prima, produto semi-elaborado, produto a granel ou produto farmacêutico acabado destinados ao combate da COVID-19 / RDC Anvisa n. 395 that alters Collegiate Board Resolution - RDC No. 352, of March 20, 2020, which provides for prior authorization for the purpose of exporting raw materials, semi-finished products, bulk products or finished pharmaceutical products for the COVID-19 combat
Brasília; CONASS; jun. 2020. (CONASS informa, 266).
Monography in Portuguese | CONASS, LILACS | ID: biblio-1100543
Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / Quarantine / Coronavirus Infections / Pandemics / Betacoronavirus Language: Portuguese Journal: CONASS informa Year: 2020 Type: Monography

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / Quarantine / Coronavirus Infections / Pandemics / Betacoronavirus Language: Portuguese Journal: CONASS informa Year: 2020 Type: Monography